U.S. Electrical Stock News

ADTRAN Holdings earnings and guidance move into focus ADTRAN Holdings (ADTN) has come under closer scrutiny after first quarter results showed higher revenue and a smaller net loss, alongside fresh second quarter revenue guidance that framed expectations for the rest of 2026. See our latest analysis for ADTRAN Holdings. Despite the latest quarterly update, the stock’s 1-day share price return of 7.38% and 7-day share price return of 17.75% were weak. However, the 90-day share price return of...

Wondering if Adecoagro's recent share price puts it at a bargain or already reflects its strengths? This article breaks down what the current valuation is really telling you. The stock last closed at US$13.37, with a 72.3% return year to date and a 59.0% return over the past year. This is set against shorter term pullbacks of 5.1% over 7 days and 11.0% over 30 days that may signal shifting sentiment around risk and reward. Recent news around global food supply resilience, agricultural input...

AppLovin (APP) just reported first quarter 2026 results that beat expectations, with revenue of US$1.84b and net income of US$1.21b. The stock reacted quickly as investors weighed the upgraded outlook. See our latest analysis for AppLovin. The latest 6.4% 1 day share price return and 21.6% 30 day share price return suggest momentum has picked up again after a weaker year to date, while the 1 year and multi year total shareholder returns remain very strong. If AppLovin's AI powered ad platform...

Q1 earnings surprise puts focus on NRG Energy stock NRG Energy (NRG) is back in the spotlight after Q1 2026 results showed revenue above expectations but earnings per share below forecasts, alongside reaffirmed full year guidance and an active build out of new Texas gas capacity. See our latest analysis for NRG Energy. The share price has retreated recently, with a 1 day share price return of a 5.83% decline and a year to date share price return of a 14.62% decline. This comes even though the...

Hawaiian Electric Industries (HE) has reported fourth quarter FY 2025 revenue of US$805.8 million and basic EPS of US$0.23, rounding out a trailing twelve month EPS of US$0.71 on revenue of about US$3.1 billion. The company has seen quarterly revenue move from US$799.2 million and EPS of US$0.17 in Q4 2024 to US$805.8 million and EPS of US$0.23 in Q4 2025. Over the same period, the trailing twelve month line has shifted from revenue of US$3.2 billion and EPS of a US$10.42 loss in Q4 2024 to...

XPeng (XPEV) is back in focus after reporting April 2026 deliveries of 31,011 vehicles, a 13% month on month rise. The company also highlighted ongoing work on physical AI projects and global expansion plans. See our latest analysis for XPeng. Despite the recent April delivery update and ongoing work on physical AI and global expansion, XPeng’s short term share price return has been weak, with a 30 day share price return of a 9.7% decline and a year to date share price return of a 23.9%...

If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be. The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x. These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for...

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

Brixmor Property Group Inc. recently reported first-quarter 2026 results showing year-on-year growth in revenue to US$354.82 million and net income to US$127.75 million, while also updating full-year guidance to net income of US$355 million to US$365 million and diluted EPS of US$1.16 to US$1.19. Alongside the earnings update, the board affirmed a quarterly dividend of US$0.3075 per share and highlighted that 2026 uncollectible revenues are expected to remain contained at 75 to 100 basis...

In early May 2026, Rackspace Technology reported first-quarter 2026 revenue of US$678.1 million and net income of US$8.3 million, marking a move back into profit from a net loss a year earlier. On the same day, Rackspace Technology and AMD announced a Memorandum of Understanding for a multiyear partnership to build a governed Enterprise AI Cloud tailored to regulated and sovereign workloads, expanding Rackspace’s role in managed AI infrastructure. Next, we’ll examine how Rackspace’s new...

Sarepta Therapeutics (NasdaqGS:SRPT) is progressing its small interfering RNA (siRNA) candidates SRP-1001 and SRP-1003, with early data viewed as encouraging. The company is seeking to transition AMONDYS 45 and VYONDYS from accelerated to traditional FDA approvals through recent regulatory submissions. These updates come as Sarepta refines its commercial focus beyond gene therapy Elevidys, which continues to face regulatory and commercial complexity. Sarepta Therapeutics focuses on rare...

Why Gold.com (GOLD) is back on investors’ radar after record Q3 results Gold.com (GOLD) is in focus after reporting record fiscal third quarter revenue of US$10.35b, a swing to net income of US$59.49m, and affirming a quarterly dividend alongside new digital asset partnerships. See our latest analysis for Gold.com. At a share price of US$43.51, Gold.com has seen a 25.14% year to date share price return and a very large 1 year total shareholder return of 114.36%. However, the 90 day share...

Star Holdings (STHO) closed out FY 2025 with Q4 revenue of US$33.4 million and a basic EPS loss of US$1.51, alongside a net loss of US$19.1 million, with trailing twelve month revenue at US$118.1 million and a TTM basic EPS loss of US$4.90. Over the past six quarters in the data, quarterly revenue has ranged from US$14.6 million to US$42.1 million while basic EPS has swung between a profit of US$6.90 and a loss of US$7.70. This sets the backdrop for a stock priced at US$8.84 today. For...

Wendy's (NasdaqGS:WEN) has announced a major franchise agreement to open up to 1,000 restaurants in China over the next decade. The expansion is part of its "Project Fresh" turnaround plan and is intended to offset weaker U.S. same-restaurant sales. The deal marks a shift in focus toward international markets as the company looks for new long term growth drivers. Wendy's, trading at around $6.95, has seen extended share price pressure, with the stock down 14.9% year to date and 39.1% over...

If you are wondering whether Chevron at around US$182.50 is offering fair value or if you are paying up for the story, this article walks through what the numbers are actually saying about the stock. The share price has pulled back recently, with a 5.6% decline over the last 7 days and a 9.4% decline over the last 30 days, while still showing returns of 17.1% year to date and 39.2% over 1 year. Recent headlines around Chevron have focused on broad energy sector sentiment and ongoing interest...

Natera (NasdaqGS:NTRA) raised its full-year 2026 revenue and gross margin guidance after reporting record test volumes. The company cited accelerating growth in both women's health and oncology segments as key drivers. Natera also outlined plans to commercially launch its Signatera MRD test in Japan, aiming to extend its international reach. Natera enters this update with its stock at $219.82 and a 1 year return of 35.2%, and a 3 year return that is a very large multiple of its earlier...

CoStar Group (NasdaqGS:CSGP) is set to be removed from the Nasdaq-100 Index. The change affects the stock's role in one of the most followed US equity benchmarks. Index adjustments can influence passive fund holdings and trading activity in the shares. For investors watching CoStar Group, the index removal intersects with a share price that most recently closed at $34.98. The stock has recorded a 1.1% return over the past week, alongside longer term declines of 11.4% over 30 days, 46.7%...

Wondering if AMETEK at around US$234.73 is offering fair value or if you might be paying up for quality? This article breaks down what the current price could mean for you. The stock has been relatively flat over the last 7 days with a 0.3% decline, but sits on gains of 7.8% over 30 days, 12.2% year to date and 37.7% over 1 year. This naturally raises questions about how much of the story is already priced in. Recent coverage has focused on AMETEK's position in the capital goods space and...

Kulicke and Soffa Industries (KLIC) has drawn fresh attention after a strong recent run in its stock, with returns over the past month and the past 3 months sharply outpacing its longer term performance. See our latest analysis for Kulicke and Soffa Industries. The recent move takes the share price to $98.15, with a 30-day share price return of 46.10% and a year-to-date share price return of 103.00%, while the 1-year total shareholder return of 215.22% highlights that momentum has been...

Why Brown & Brown (BRO) is Back on Investors’ Radar Brown & Brown (BRO) has drawn fresh attention after recent trading left the stock about 25% lower year to date, with the share price at US$58.05 and a market value near US$19.2b. See our latest analysis for Brown & Brown. The 1-day share price return of 2.63% sits against a 30-day share price return of 12.54% and a year to date share price return of 25.21%. The 1-year total shareholder return of 47.57% contrasts with a 3-year total...

This article examines whether Energizer Holdings, at US$18.56, could be a bargain or a value trap, and explains what the current share price might be implying. The stock has recently seen mixed returns, with an 11.1% gain over the last 30 days but declines of 5.2% over 7 days, 6.9% year to date, and 11.5% over 1 year, extending to 39.8% over 3 years and 52.2% over 5 years. Recent coverage has focused on how Energizer Holdings fits into the broader household products sector, as investors...

DorianG (LPG) has been drawing attention after recent share price strength. The stock’s value score of 3 and an intrinsic discount of 38.4% are prompting closer scrutiny from income and value focused investors. See our latest analysis for DorianG. The recent 16.78% 1-month share price return and 23.06% 3-month share price return suggest momentum is building, set against a 99% 1-year total shareholder return and the current $39.81 share price relative to its assessed discount. If this kind of...

AdvanSix (ASIX) closed out FY 2025 with Q4 revenue of US$359.9 million and a basic EPS loss of US$0.10. The trailing twelve months show EPS of US$1.83 on revenue of about US$1.5 billion. Over recent periods, revenue has moved from US$329.1 million in Q4 2024 to US$410.0 million in Q2 2025. Quarterly EPS has ranged from a small profit of US$0.01 in Q4 2024 to a high of US$1.17 in Q2 2025, giving investors a mix of profitable quarters and losses at the year end. With net profit margin at 3.2%...